Date published: 2025-12-11

00800 4573 8000

SCBT Portrait Logo
Seach Input

Lefty Inhibitoren

Lefty inhibitors belong to a distinct class of chemical compounds known for their pivotal role in regulating embryonic development and cell differentiation. These inhibitors are closely associated with the transforming growth factor-beta (TGF-β) superfamily of signaling molecules. To understand Lefty inhibitors, it's essential to appreciate their role within the intricate process of embryogenesis. During early development, Lefty inhibitors play a fundamental role in establishing the body plan of an organism. They are known for their function in maintaining symmetry and axis formation, a critical step in the early stages of embryonic development. Lefty inhibitors act as antagonists to certain signaling pathways within the TGF-β superfamily, exerting their influence by interfering with the signaling molecules involved. Specifically, they counteract the activity of Nodal, an important TGF-β member, which plays a key role in specifying the left-right axis in vertebrates. By doing so, Lefty inhibitors help ensure that the developing embryo forms with appropriate bilateral symmetry, preventing developmental abnormalities and ensuring the proper organization of vital organs.

Lefty inhibitors can be broadly classified into two isoforms: Lefty-1 and Lefty-2. Both isoforms exhibit similar mechanisms of action, working as negative regulators by binding to Nodal and inhibiting its signaling. This function is crucial for maintaining the balance of the Nodal pathway, preventing excessive or inappropriate signaling that could lead to developmental defects. Lefty inhibitors are a prime example of the delicate checks and balances that govern embryonic development. Their presence ensures the precise orchestration of signaling pathways, guaranteeing that an organism's body plan and symmetry are established correctly during its early stages of development. Understanding the mechanisms of Lefty inhibitors is not only essential for developmental biology but also holds potential implications for various fields of science and medicine, shedding light on the intricacies of cell signaling and differentiation.

Siehe auch...

Artikel 11 von 15 von insgesamt 15

Anzeigen:

ProduktCAS #Katalog #MengePreisReferenzenBewertung

Lapatinib

231277-92-2sc-353658
100 mg
$412.00
32
(1)

Lapatinib ist ein dualer EGFR- und HER2-Inhibitor, der Tyrosinkinasen hemmt und so das Wachstum und die Ausbreitung von HER2-positiven Brustzellen verhindert.

Vemurafenib

918504-65-1sc-364643
sc-364643A
10 mg
50 mg
$115.00
$415.00
11
(1)

Vemurafenib hemmt spezifisch BRAF-V600E-Mutationen und stoppt die unkontrollierte Vermehrung von Melanomzellen mit dieser spezifischen Mutation.

Regorafenib

755037-03-7sc-477163
sc-477163A
25 mg
50 mg
$320.00
$430.00
3
(0)

Regorafenib ist ein Multi-Kinase-Inhibitor, der auf angiogene Rezeptoren, stromale Kinasen und onkogene Kinasen abzielt, was zur Kontrolle von Wachstum und Angiogenese beiträgt.

Osimertinib

1421373-65-0sc-507355
5 mg
$86.00
(0)

Osimertinib ist ein EGFR-Tyrosinkinase-Hemmer, der auf EGFR-T790M-Mutationen abzielt und die Resistenz bei Patienten mit nicht-kleinzelligem Lungenkrebs (NSCLC) überwindet.

5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine

1032900-25-6sc-505041
1 mg
$230.00
(0)

Ceritinib hemmt die ALK- und ROS1-Kinasen, die speziell bei der Erforschung von nicht-kleinzelligem Lungenkrebs (NSCLC) mit ALK- oder ROS1-Gen-Rearrangements untersucht wurden, und blockiert das Tumorwachstum.